ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

75pharma Group Limited

75pharma Group Limited is an active company incorporated on 22 January 2021 with the registered office located in London, Greater London. 75pharma Group Limited was registered 4 years ago.
Status
Active
Active since incorporation
Company No
13152498
Private limited company
Age
4 years
Incorporated 22 January 2021
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 21 January 2025 (9 months ago)
Next confirmation dated 21 January 2026
Due by 4 February 2026 (2 months remaining)
Last change occurred 9 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2023 (12 months)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2024
Due by 31 December 2025 (1 month remaining)
Address
123 Buckingham Palace Road
London
SW1W 9SH
United Kingdom
Same address for the past 4 years
Telephone
Unreported
Email
Unreported
People
Officers
8
Shareholders
2
Controllers (PSC)
2
Director • Director • British • Lives in UK • Born in Sep 1966
Director • Finnish • Lives in Finland • Born in Jul 1967
Director • Finnish • Lives in Finland • Born in Jul 1983
Director • Finnish • Lives in Finland • Born in Sep 1986
Director • British • Lives in UK • Born in May 1958
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
RK Developments (UK) Limited
Parul Kanabar is a mutual person.
Active
75pharma Limited
Sunita Pall and Niko Johannes Nevala are mutual people.
Active
75PH Impact Limited
Pasi Petteri Ruokostenpohja and Sunita Pall are mutual people.
Active
Hospice Of St. Francis (Berkhamsted) Limited
Parul Kanabar is a mutual person.
Active
Emerald UK Investments Ltd
Sunita Pall is a mutual person.
Active
Abundance And Growth Ltd
Sunita Pall is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2021–2023)
Period Ended
31 Dec 2023
For period 31 Dec31 Dec 2023
Traded for 12 months
Cash in Bank
£1.83K
Decreased by £27.65K (-94%)
Turnover
Unreported
Same as previous period
Employees
1
Same as previous period
Total Assets
£256.05K
Decreased by £679.99K (-73%)
Total Liabilities
-£385.82K
Increased by £150.16K (+64%)
Net Assets
-£129.77K
Decreased by £830.15K (-119%)
Debt Ratio (%)
151%
Increased by 125.51% (+499%)
Latest Activity
Miss Sunita Pall Appointed
4 Months Ago on 24 Jun 2025
Mr Marko Tapio Hakkinen Appointed
4 Months Ago on 24 Jun 2025
Ms Tessa Koivunen Appointed
4 Months Ago on 24 Jun 2025
Mr John Mills Appointed
4 Months Ago on 24 Jun 2025
Parul Kanabar Resigned
4 Months Ago on 24 Jun 2025
Mr Pasi Petteri Ruokostenpohja (PSC) Details Changed
8 Months Ago on 14 Mar 2025
Ms Parul Kanabar Appointed
8 Months Ago on 1 Mar 2025
Confirmation Submitted
9 Months Ago on 18 Feb 2025
Mr Pasi Petteri Ruokostenpohja (PSC) Details Changed
10 Months Ago on 15 Jan 2025
Mr Niko Johannes Nevala (PSC) Details Changed
1 Year 4 Months Ago on 1 Jul 2024
Get Credit Report
Discover 75pharma Group Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Resolutions
Submitted on 20 Oct 2025
Memorandum and Articles of Association
Submitted on 20 Oct 2025
Statement of company's objects
Submitted on 20 Oct 2025
Statement of capital following an allotment of shares on 30 June 2025
Submitted on 23 Jul 2025
Appointment of Miss Sunita Pall as a director on 24 June 2025
Submitted on 9 Jul 2025
Appointment of Mr John Mills as a director on 24 June 2025
Submitted on 9 Jul 2025
Termination of appointment of Parul Kanabar as a director on 24 June 2025
Submitted on 9 Jul 2025
Appointment of Mr Marko Tapio Hakkinen as a director on 24 June 2025
Submitted on 9 Jul 2025
Appointment of Ms Tessa Koivunen as a director on 24 June 2025
Submitted on 9 Jul 2025
Appointment of Ms Parul Kanabar as a director on 1 March 2025
Submitted on 31 Mar 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year